These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12324708)

  • 1. Increased expression but not genetic alteration of BRG1, a component of the SWI/SNF complex, is associated with the advanced stage of human gastric carcinomas.
    Sentani K; Oue N; Kondo H; Kuraoka K; Motoshita J; Ito R; Yokozaki H; Yasui W
    Pathobiology; 2001; 69(6):315-20. PubMed ID: 12324708
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRG1, a component of the SWI-SNF complex, is mutated in multiple human tumor cell lines.
    Wong AK; Shanahan F; Chen Y; Lian L; Ha P; Hendricks K; Ghaffari S; Iliev D; Penn B; Woodland AM; Smith R; Salada G; Carillo A; Laity K; Gupte J; Swedlund B; Tavtigian SV; Teng DH; Lees E
    Cancer Res; 2000 Nov; 60(21):6171-7. PubMed ID: 11085541
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear or cytoplasmic localization of Bag-1 distinctly correlates with pathologic behavior and outcome of gastric carcinomas.
    Zheng HC; Xu XY; Xing YN; Wei ZL; Takahashi H; Masuda S; Takano Y
    Hum Pathol; 2010 May; 41(5):724-36. PubMed ID: 20096920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Frequent loss of RUNX3 expression by promoter hypermethylation in gastric carcinoma.
    Oshimo Y; Oue N; Mitani Y; Nakayama H; Kitadai Y; Yoshida K; Ito Y; Chayama K; Yasui W
    Pathobiology; 2004; 71(3):137-43. PubMed ID: 15051926
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcriptional targets of the chromatin-remodelling factor SMARCA4/BRG1 in lung cancer cells.
    Medina PP; Carretero J; Ballestar E; Angulo B; Lopez-Rios F; Esteller M; Sanchez-Cespedes M
    Hum Mol Genet; 2005 Apr; 14(7):973-82. PubMed ID: 15731117
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of the SWI/SNF chromatin remodelling subunit-BRG1 and BRM in hepatocellular carcinoma.
    Endo M; Yasui K; Zen Y; Gen Y; Zen K; Tsuji K; Dohi O; Mitsuyoshi H; Tanaka S; Taniwaki M; Nakanuma Y; Arii S; Yoshikawa T
    Liver Int; 2013 Jan; 33(1):105-17. PubMed ID: 23088494
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concomitant down-regulation of BRM and BRG1 in human tumor cell lines: differential effects on RB-mediated growth arrest vs CD44 expression.
    Reisman DN; Strobeck MW; Betz BL; Sciariotta J; Funkhouser W; Murchardt C; Yaniv M; Sherman LS; Knudsen ES; Weissman BE
    Oncogene; 2002 Feb; 21(8):1196-207. PubMed ID: 11850839
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The altered expression of ING5 protein is involved in gastric carcinogenesis and subsequent progression.
    Xing YN; Yang X; Xu XY; Zheng Y; Xu HM; Takano Y; Zheng HC
    Hum Pathol; 2011 Jan; 42(1):25-35. PubMed ID: 21062663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutation and expression of the p27KIP1 and p57KIP2 genes in human gastric cancer.
    Shin JY; Kim HS; Lee KS; Kim J; Park JB; Won MH; Chae SW; Choi YH; Choi KC; Park YE; Lee JY
    Exp Mol Med; 2000 Jun; 32(2):79-83. PubMed ID: 10926119
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inactivation of helicase-like transcription factor by promoter hypermethylation in human gastric cancer.
    Leung WK; Yu J; Bai AH; Chan MW; Chan KK; To KF; Chan FK; Ng EK; Chung SC; Sung JJ
    Mol Carcinog; 2003 Jun; 37(2):91-7. PubMed ID: 12766908
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of MRE11 complex (MRE11, RAD50, NBS1) and hRap1 and its relation with telomere regulation, telomerase activity in human gastric carcinomas.
    Matsutani N; Yokozaki H; Tahara E; Tahara H; Kuniyasu H; Kitadai Y; Haruma K; Chayama K; Tahara E; Yasui W
    Pathobiology; 2001; 69(4):219-24. PubMed ID: 12007281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. No mutations of the Bub1 gene in human gastric and oral cancer cell lines.
    Nakagawa H; Yokozaki H; Oue N; Sugiyama M; Ishikawa T; Tahara E; Yasui W
    Oncol Rep; 2002; 9(6):1229-32. PubMed ID: 12375025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A synthetic lethality-based strategy to treat cancers harboring a genetic deficiency in the chromatin remodeling factor BRG1.
    Oike T; Ogiwara H; Tominaga Y; Ito K; Ando O; Tsuta K; Mizukami T; Shimada Y; Isomura H; Komachi M; Furuta K; Watanabe S; Nakano T; Yokota J; Kohno T
    Cancer Res; 2013 Sep; 73(17):5508-18. PubMed ID: 23872584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Demethylation of the synuclein gamma gene CpG island in primary gastric cancers and gastric cancer cell lines.
    Yanagawa N; Tamura G; Honda T; Endoh M; Nishizuka S; Motoyama T
    Clin Cancer Res; 2004 Apr; 10(7):2447-51. PubMed ID: 15073123
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of EphA1 in gastric carcinomas is associated with metastasis and survival.
    Wang J; Dong Y; Wang X; Ma H; Sheng Z; Li G; Lu G; Sugimura H; Zhou X
    Oncol Rep; 2010 Dec; 24(6):1577-84. PubMed ID: 21042754
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aberrant expression of SWI/SNF catalytic subunits BRG1/BRM is associated with tumor development and increased invasiveness in prostate cancers.
    Sun A; Tawfik O; Gayed B; Thrasher JB; Hoestje S; Li C; Li B
    Prostate; 2007 Feb; 67(2):203-13. PubMed ID: 17075831
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic and epigenetic screening for gene alterations of the chromatin-remodeling factor, SMARCA4/BRG1, in lung tumors.
    Medina PP; Carretero J; Fraga MF; Esteller M; Sidransky D; Sanchez-Cespedes M
    Genes Chromosomes Cancer; 2004 Oct; 41(2):170-7. PubMed ID: 15287030
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SCF
    Huang LY; Zhao J; Chen H; Wan L; Inuzuka H; Guo J; Fu X; Zhai Y; Lu Z; Wang X; Han ZG; Sun Y; Wei W
    Nat Commun; 2018 Sep; 9(1):3569. PubMed ID: 30177679
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanism of BRG1 silencing in primary cancers.
    Marquez-Vilendrer SB; Thompson K; Lu L; Reisman D
    Oncotarget; 2016 Aug; 7(35):56153-56169. PubMed ID: 27486753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Genetic and epigenetic alterations of BRG1 promote oral cancer development.
    Gunduz E; Gunduz M; Ouchida M; Nagatsuka H; Beder L; Tsujigiwa H; Fukushima K; Nishizaki K; Shimizu K; Nagai N
    Int J Oncol; 2005 Jan; 26(1):201-10. PubMed ID: 15586241
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.